Skip to main content

Table 2 Measures and timing of assessment in the Melanoma care study

From: The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease

Variables

Measures

Baseline (T0)

T1*

T2Φ

T3‡

Fear of new or recurrent melanoma

Fear of Cancer Recurrence Inventory

✓

✓

✓

✓

Depression, anxiety, stress and depression

Depression Anxiety and Stress Scales (DASS-21)

✓

✓

✓

✓

Health related quality of life

AQOL-8D and FACT-M

✓

 

✓

✓

Knowledge

A 9 item scale specifically developed for this study

✓

✓

✓

✓

Healthy behavioural adjustment to melanoma risk

The Sun Protection Habits Scale (SPHS) and adapted items for sun protection and skin self examination

✓

 

✓

✓

Satisfaction with clinical care

Consultation Satisfaction Questionnaire (CSQ)

✓

✓

✓

 

Unmet information and support needs

Modified Cancer Survivors’ Unmet Needs (CaSUN)

✓

✓

✓

 

Resource use and cost outcomes

Items developed for this study (resource use) and Medicare data (PBS and MBS)

✓

 

✓

✓

Health literacy

 

✓

   

Medical record

From the melanoma clinics’ databases

✓

 

✓

✓

Process evaluation

Developed for use in this study.

✓

 

✓

 

Demographic and other risk factors

Age, gender, marital status, number of children, education, income, occupation

✓

   
  1. *T1: 6 weeks after randomisation, ΦT2: 7 months after randomisation, ‡T3: 13 months after randomisation